Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study

by Castro M, Rode J, Machado PRL, Llanos-Cuentas A, Hueb M, Cota G, Rojas IV, Orobio Y, Sarmiento OO, Rojas E, Quintero J, Pimentel MIF, Soto J, Suprien C, Alvarez F, Ramos AP, Arantes RBdS, da Silva RE, Arenas CM, Vélez ID, Lyra MR, Saravia NG, Arana B, Alexander N. PLOS Neglected Tropical Diseases 2023, 17(1):e0011029. doi: 10.1371/journal.pntd.0011029

Summary: Treatment guidance for children and older adults affected by cutaneous leishmaniasis is unclear, due to limited representation of these groups in clinical trials. RedeLEISH, a Latin American network of leishmaniasis researchers, conducted a collaborative retrospective study to describe the effectiveness and safety of antileishmanial treatments in children and older adults in ten cutaneous leishmaniasis referral centers in Latin America. Patient records for 736 children and 589 older adults showed that the disease presents predominantly in a mild form, and that the most commonly used treatment, systemic antimonials, has limited effectiveness, with cure rates of 54.6% and 68.2%, respectively. Alternatives to systemic antimonials and development of strategies to improve patient follow-up across the region are needed.

Please note that this article is an uncorrected proof.

The post Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study first appeared on DNDi.

Ajude os pacientes negligenciados

Até o momento, desenvolvemos nove tratamentos para doenças negligenciadas, salvando milhões de vidas. Temos o objetivo de disponibilizar 25 novos tratamentos em nossos primeiros 25 anos. Você pode nos ajudar!

Organização internacional, sem fins lucrativos, que desenvolve tratamentos seguros, eficazes e acessíveis para os pacientes mais negligenciados.

DNDi Global

Entre em contato

DNDi pelo mundo

Apoie a DNDi

Faça uma doação!

Trabalhe conosco

Oportunidades

Exceto para imagens, filmes e marcas registradas que estão sujeitos aos Termos de Uso da DNDi, o conteúdo deste site está licenciado sob uma Licença Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License.